No Data
No Data
Stifel Nicolaus Remains a Hold on Atara Biotherapeutics (ATRA)
CCORF Maintains Atara Biotherapeutics(ATRA.US) With Buy Rating, Maintains Target Price $17
Atara Biotherapeutics: Strategic Focus on Ebvallo BLA Resubmission and Market Position Enhancement
Atara Biotherapeutics Price Target Maintained With a $17.00/Share by Canaccord Genuity
Atara Biotherapeutics Is Maintained at Buy by Canaccord Genuity
Atara Biotherapeutics Analyst Ratings
kingrotch : thank you for your work


真名有晨 : Thank you very much
Please take care and rest.
iluvpoptarts : sry doc. I'm too busy counting the money your making me too look. muha
IamBadNewz : @Jaguar8 Been waiting (im)patiently for a pop on CGTX given the recent conference and news of insider buying but price hasn’t reacted. Your thoughts?
Jaguar8 OP IamBadNewz : You have to be patient
View more comments...